Cite
Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin.
MLA
Pagano, Maria Teresa, et al. “Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin.” International Journal of Molecular Sciences, vol. 23, no. 18, Sept. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/ijms231810417.
APA
Pagano, M. T., Fecchi, K., Pierdominici, M., Ortona, E., & Peruzzu, D. (2022). Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin. International Journal of Molecular Sciences, 23(18), N.PAG. https://doi.org/10.3390/ijms231810417
Chicago
Pagano, Maria Teresa, Katia Fecchi, Marina Pierdominici, Elena Ortona, and Daniela Peruzzu. 2022. “Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin.” International Journal of Molecular Sciences 23 (18): N.PAG. doi:10.3390/ijms231810417.